3T Biosciences 27-slide pitch deck to raise $40M Series A · page 16 of 27
The slide uses a contrast-pair framework to highlight the limitation of current therapies (~25% targetable) versus the expanded capability of the company's platform.
Pitch deck · solution · present_solution · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 2/2 framework 1/1 image 1/1 title 1/1
Components 5
primary primary instance illustration headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1